Dr. Jia Lin, MD

Dr. Lin practices at Ut Physicians Neurosciences in Houston, Texas.

Dr. Lin's NPI, 1730613126, was assigned on April 12, 2017. Dr. Lin graduated from University of Colorado Anschutz Medical Campus in 2016. Dr. Lin holds Texas license T9440.

Dr. Lin's primary practice is Ut Physicians Neurosciences, at 6410 Fannin St Ste 1014 Suite 1014, Houston, TX 77030. The practice phone is (832) 325-7080.

Dr. Lin's primary practice is Ut Physicians Neurosciences in Houston, Texas. Dr. Lin is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UTHealth Houston Neurosciences, Texas Medical Center. Dmand AI also links Dr. Lin to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lin is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Lin's licenses on file in 3 states: Texas, California and Michigan.

Dmand AI lists lower back pain, multiple sclerosis and neuropathy among the conditions Dr. Lin treats.

CMS data shows 97 Medicare services from Dr. Lin across 4 procedure codes in 2024, for 51 Medicare patients. Medicare paid $8,035 for them. Every service was in an office.

CMS counts 51 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 21 patients. 67% of them have high blood pressure, and 63% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 44, with 73% women.

In 2024, Dr. Lin wrote 266 Medicare Part D claims for 56 patients. 78% of them were for generic drugs. CMS names the drug for 141 of them, across 7 drugs with 11 or more claims each, at $230,242 in total drug cost. In 2023, CMS named 43 claims across 3 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 45 papers to Dr. Lin, published from 2011 to 2025. 2025 was the busiest year, with 7. The most frequent topics are Acute Coronary Syndrome, Clopidogrel and DNA Methylation. Dr. Lin has published most often in Phys Chem Chem Phys. Dr. Lin's most frequent co-authors are Helena Bulka, DO, Mirela Cerghet, MD, PhD and Farhan Chaudhry, MD.

CMS Open Payments shows 88 general payments to Dr. Lin from 16 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $723.

Dr. Lin graduated from University of Colorado Anschutz Medical Campus in 2016.

Dr. Lin is in network with 22 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.